Schizophrenia

Schizophrenia is a chronic and often severe psychotic disorder characterised by positive symptoms (hallucinations and delusions), negative symptoms (such as blunted affect and avolition), disorganisation, and cognitive impairment. It typically begins in late adolescence or early adulthood and is a leading cause of long-term disability worldwide.

Definition

Schizophrenia is a psychotic disorder defined by the persistent presence of characteristic symptoms - delusions, hallucinations, disorganised speech, grossly disorganised or catatonic behaviour, and negative symptoms - causing significant functional impairment over an extended period, as specified in DSM-5-TR and ICD-11.

Scope

This entry covers schizophrenia as a defined clinical entity: its core symptom domains, diagnostic conceptualisation, neurobiological models, epidemiology and course, and the evidence base summarised in major reviews and meta-analyses. It is reference-educational and does not provide diagnostic or treatment instructions.

Core questions

• How are the positive, negative, and cognitive symptom domains defined and measured?
• What neurobiological mechanisms best account for the symptoms and their course?
• What is known about the epidemiology, prognosis, and excess mortality associated with the disorder?

Key concepts

• Positive symptoms
• Negative symptoms
• Cognitive impairment
• Disorganisation
• Prodrome
• Neurodevelopment
• Excess mortality

Key theories

Dopamine hypothesis (version III)

Howes and Kapur reframed the dopamine hypothesis to centre on presynaptic striatal dopamine dysregulation as the final common pathway, through which genetic, environmental, and developmental risk factors converge to produce psychosis.

Neurodevelopmental model

Schizophrenia is conceptualised as arising from early disruptions of brain development that interact with later maturational and environmental factors, manifesting clinically in late adolescence or early adulthood.

Mechanisms

Positive symptoms are most strongly linked to dysregulated presynaptic striatal dopamine signalling, the basis of the dopamine hypothesis as articulated by Howes and Kapur. Negative and cognitive features are associated with broader cortical, glutamatergic, and circuit-level dysfunction. The disorder is widely framed as neurodevelopmental, with polygenic genetic risk and environmental exposures converging on shared neural pathways described by Owen and colleagues and by Marder and Cannon.

Clinical relevance

Schizophrenia accounts for a large share of psychiatric disability and is associated with substantial excess mortality, much of it from physical illness. Understanding its symptom structure and evidence base supports critical appraisal of research on course and outcomes; this entry is educational and not a guide to individual care.

Epidemiology

Lifetime risk is on the order of roughly one percent, with onset typically in late adolescence to early adulthood and a somewhat earlier and more severe course in men on average. A population-based cohort study by Tiihonen and colleagues documented marked excess mortality among patients, underscoring the disorder's physical-health burden.

Evidence & guidelines

Diagnosis follows DSM-5-TR and ICD-11 criteria. Comparative meta-analytic evidence on antipsychotic efficacy and tolerability is summarised by Leucht and colleagues (2013), and broad clinical syntheses are provided by Owen and colleagues (2016) and Marder and Cannon (2019).

History

Kraepelin described dementia praecox as a deteriorating illness distinct from manic-depressive insanity; Bleuler renamed it schizophrenia and emphasised the splitting of psychic functions and thought disorder, while Schneider proposed first-rank symptoms to aid diagnosis. These concepts shaped the operationalised criteria now used in DSM-5-TR and ICD-11.

Debates

Is schizophrenia a single disease or a heterogeneous syndrome?

Substantial clinical and genetic heterogeneity has led to debate over whether schizophrenia represents one disorder or a final common presentation of multiple distinct etiologies, with implications for research stratification.

Key figures

• Emil Kraepelin
• Eugen Bleuler
• Kurt Schneider

Seminal works

• howes-2009
• owen-2016
• leucht-2013
• tiihonen-2009

Frequently asked questions

Does schizophrenia mean having a split personality?

No. Schizophrenia is not dissociative identity disorder. The name refers historically to a splitting or disintegration of mental functions such as thought, emotion, and perception, not to multiple personalities.

When does schizophrenia usually begin?

Onset is most commonly in late adolescence to early adulthood, often preceded by a prodromal phase of attenuated symptoms and declining function, with men tending to present somewhat earlier than women on average.